Heart Failure Reviews

, Volume 14, Issue 3, pp 183–193 | Cite as

Sleep-disordered breathing in patients with decompensated heart failure

  • Martin A. Valdivia-Arenas
  • Michael Powers
  • Rami N. Khayat


Sleep-disordered breathing (SDB) has a higher prevalence in patients with heart failure than in the general middle-aged population. Obstructive sleep apnea (OSA), one of the forms of SBD, promotes poorly controlled hypertension, coronary events, and atrial fibrillation events that can lead to acutely decompensated heart failure (ADHF), and evidence suggests that untreated OSA increases mortality in patients with heart failure. Cheyne–Stokes respiration and central sleep apnea (CSA) have long been associated with heart failure and, in many patients, can coexist with OSA. In this article, we propose a systematic approach to diagnose and treat OSA in patients with ADHF based on current evidence.


Acutely decompensated heart failure Obstructive sleep apnea Central sleep apnea Sleep-disordered breathing Cheyne–Stokes respiration 


  1. 1.
    Shahar E et al (2001) Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163(1):19–25PubMedGoogle Scholar
  2. 2.
    Nieto FJ et al (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. J Am Med Assoc 283(14):1829–1836. doi: 10.1001/jama.283.14.1829
  3. 3.
    Parker JD et al (1999) Acute and chronic effects of airway obstruction on canine left ventricular performance. Am J Respir Crit Care Med 160(6):1888–1896PubMedGoogle Scholar
  4. 4.
    Marin JM et al (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365(9464):1046–1053PubMedGoogle Scholar
  5. 5.
    Rosamond W et al (2007) Heart disease and stroke statistics–2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115(5):e69–e171. doi: 10.1161/CIRCULATIONAHA.106.179918 PubMedGoogle Scholar
  6. 6.
    O’Connell JB (2000) The economic burden of heart failure. Clin Cardiol 23(3, Suppl):III6–III10Google Scholar
  7. 7.
    Elkayam U et al (2007) Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure. Am Heart J 153(1):98–104. doi: 10.1016/j.ahj.2006.09.005 PubMedGoogle Scholar
  8. 8.
    Nieminen MS et al (2005) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26(4):384–416. doi: 10.1093/eurheartj/ehi044 PubMedGoogle Scholar
  9. 9.
    Naughton MT (2006) The link between obstructive sleep apnea and heart failure: underappreciated opportunity for treatment. Curr Heart Fail Rep 3(4):183–188. doi: 10.1007/s11897-006-0020-z PubMedGoogle Scholar
  10. 10.
    Young T et al (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328(17):1230–1235. doi: 10.1056/NEJM199304293281704 PubMedGoogle Scholar
  11. 11.
    Javaheri S et al (1998) Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97(21):2154–2159PubMedGoogle Scholar
  12. 12.
    Sin DD et al (1999) Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160(4):1101–1106PubMedGoogle Scholar
  13. 13.
    Oldenburg O et al (2007) Prevalence of sleep-related breathing disorders in ischemic and non-ischemic heart failure. Deut Med Wochenschr 132(13):661–666. doi: 10.1055/s-2007-973599 Google Scholar
  14. 14.
    Oldenburg O et al (2007) Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 9(3):251–257. doi: 10.1016/j.ejheart.2006.08.003 PubMedGoogle Scholar
  15. 15.
    Ferrier K et al (2005) Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest 128(4):2116–2122. doi: 10.1378/chest.128.4.2116 PubMedGoogle Scholar
  16. 16.
    Schulz R et al (2007) Sleep apnoea in heart failure. Eur Respir J 29(6):1201–1205. doi: 10.1183/09031936.00037106 PubMedGoogle Scholar
  17. 17.
    Nieminen MS et al (2006) EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27(22):2725–2736. doi: 10.1093/eurheartj/ehl193 PubMedGoogle Scholar
  18. 18.
    Adams KF Jr et al (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149(2):209–216. doi: 10.1016/j.ahj.2004.08.005 PubMedGoogle Scholar
  19. 19.
    Wang H et al (2007) Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 49(15):1625–1631. doi: 10.1016/j.jacc.2006.12.046 PubMedGoogle Scholar
  20. 20.
    Pack AI, Goldberg LR (2006) Routine polysomnography is not indicated in congestive heart failure. J Clin Sleep Med 01(01):19–22Google Scholar
  21. 21.
    Franklin KA (2007) Sleep apnoea screening in heart failure? Not until benefit is proven! Eur Respir J 29(6):1073–1074. doi: 10.1183/09031936.00030507 Google Scholar
  22. 22.
    Xie A et al (2002) Apnea-hypopnea threshold for CO2 in patients with congestive heart failure. Am J Respir Crit Care Med 165(9):1245–1250. doi: 10.1164/rccm.200110-022OC PubMedGoogle Scholar
  23. 23.
    Francis GS et al (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82(5):1724–1729PubMedGoogle Scholar
  24. 24.
    Chenuel BJ et al (2006) Increased propensity for apnea in response to acute elevations in left atrial pressure during sleep in the dog. J Appl Physiol 101(1):76–83. doi: 10.1152/japplphysiol.01617.2005 PubMedGoogle Scholar
  25. 25.
    Shepard JW Jr et al (1996) Effects of changes in central venous pressure on upper airway size in patients with obstructive sleep apnea. Am J Respir Crit Care Med 153(1):250–254PubMedGoogle Scholar
  26. 26.
    Tkacova R et al (2001) Overnight shift from obstructive to central apneas in patients with heart failure: role of PCO2 and circulatory delay. Circulation 103(2):238–243PubMedGoogle Scholar
  27. 27.
    Morgan BJ, Denahan T, Ebert TJ (1993) Neurocirculatory consequences of negative intrathoracic pressure vs. asphyxia during voluntary apnea. J Appl Physiol 74(6):2969–2975Google Scholar
  28. 28.
    Katragadda S et al (1997) Neural mechanism of the pressor response to obstructive and nonobstructive apnea. J Appl Physiol 83(6):2048–2054PubMedGoogle Scholar
  29. 29.
    Dempsey JA (2005) Crossing the apnoeic threshold: causes and consequences. Exp Physiol 90(1):13–24. doi: 10.1113/expphysiol.2004.028985 PubMedGoogle Scholar
  30. 30.
    Xie A et al (2005) Cerebrovascular response to carbon dioxide in patients with congestive heart failure. Am J Respir Crit Care Med 172(3):371–378. doi: 10.1164/rccm.200406-807OC PubMedGoogle Scholar
  31. 31.
    Chiu KL et al (2006) Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects. Am J Respir Crit Care Med 174(12):1378–1383. doi: 10.1164/rccm.200607-927OC PubMedGoogle Scholar
  32. 32.
    Harms CA et al (1996) Negative pressure-induced deformation of the upper airway causes central apnea in awake and sleeping dogs. J Appl Physiol 80(5):1528–1539PubMedGoogle Scholar
  33. 33.
    Badr MS et al (1995) Pharyngeal narrowing/occlusion during central sleep apnea. J Appl Physiol 78(5):1806–1815PubMedGoogle Scholar
  34. 34.
    Jordan AS, White DP (2008) Pharyngeal motor control and the pathogenesis of obstructive sleep apnea. Respir Physiol Neurobiol 160(1):1–7. doi: 10.1016/j.resp.2007.07.009 Google Scholar
  35. 35.
    Somers VK et al (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96(4):1897–1904. doi: 10.1172/JCI118235 PubMedGoogle Scholar
  36. 36.
    Fletcher EC (2003) Sympathetic over activity in the etiology of hypertension of obstructive sleep apnea. Sleep 26(1):15–19PubMedGoogle Scholar
  37. 37.
    Bradley TD et al (2005) Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 353(19):2025–2033. doi: 10.1056/NEJMoa051001 PubMedGoogle Scholar
  38. 38.
    Ryan CM et al (2005) Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 60(9):781–785. doi: 10.1136/thx.2005.040972 PubMedGoogle Scholar
  39. 39.
    Naughton MT et al (1995) Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation 91(6):1725–1731PubMedGoogle Scholar
  40. 40.
    Bradley TD, Floras JS (2003) Sleep apnea and heart failure: Part I: obstructive sleep apnea. Circulation 107(12):1671–1678. doi: 10.1161/01.CIR.0000061757.12581.15 PubMedGoogle Scholar
  41. 41.
    Fletcher EC et al (1999) Pulmonary edema develops after recurrent obstructive apneas. Am J Respir Crit Care Med 160(5 Pt 1):1688–1696Google Scholar
  42. 42.
    Leuenberger U et al (1995) Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol 79(2):581–588PubMedGoogle Scholar
  43. 43.
    Waradekar NV et al (1996) Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 153(4 Pt 1):1333–1338Google Scholar
  44. 44.
    Bolger AP et al (2002) Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 106(1):92–99. doi: 10.1161/01.CIR.0000020009.30736.3F PubMedGoogle Scholar
  45. 45.
    Francis GS et al (1993) Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation 87(6, Suppl):VI40–VI48Google Scholar
  46. 46.
    Khayat RN et al (2004) Role of sensory input from the lungs in control of muscle sympathetic nerve activity during and after apnea in humans. J Appl Physiol 97(2):635–640. doi: 10.1152/japplphysiol.00241.2004 PubMedGoogle Scholar
  47. 47.
    Kato M et al (2000) Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102(21):2607–2610PubMedGoogle Scholar
  48. 48.
    Leuenberger UA et al (2001) Hypoxia augments apnea-induced peripheral vasoconstriction in humans. J Appl Physiol 90(4):1516–1522PubMedGoogle Scholar
  49. 49.
    Imadojemu VA et al (2002) Obstructive apnea during sleep is associated with peripheral vasoconstriction. Am J Respir Crit Care Med 165(1):61–66PubMedGoogle Scholar
  50. 50.
    Yang A et al (2005) Influence of obstructive sleep apnea on heart rate turbulence. Basic Res Cardiol 100(5):439–445. doi: 10.1007/s00395-005-0536-5 PubMedGoogle Scholar
  51. 51.
    Roche F et al (1999) Reduced cardiac sympathetic autonomic tone after long-term nasal continuous positive airway pressure in obstructive sleep apnoea syndrome. Clin Physiol (Oxford, England) 19(2):127–134. doi: 10.1046/j.1365-2281.1999.00163.x Google Scholar
  52. 52.
    Peppard PE et al (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342(19):1378–1384. doi: 10.1056/NEJM200005113421901 PubMedGoogle Scholar
  53. 53.
    Young T et al (1997) Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157(15):1746–1752. doi: 10.1001/archinte.157.15.1746 PubMedGoogle Scholar
  54. 54.
    Hla KM et al (1994) Sleep apnea and hypertension. A population-based study. Ann Intern Med 120(5):382–388Google Scholar
  55. 55.
    Brooks D et al (1997) Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 99(1):106–109. doi: 10.1172/JCI119120 Google Scholar
  56. 56.
    Wilcox I et al (1993) Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. Sleep 16(6):539–544PubMedGoogle Scholar
  57. 57.
    Becker HF et al (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107(1):68–73. doi: 10.1161/01.CIR.0000042706.47107.7A PubMedGoogle Scholar
  58. 58.
    Gami AS et al (2004) Association of atrial fibrillation and obstructive sleep apnea. Circulation 110(4):364–367. doi: 10.1161/01.CIR.0000136587.68725.8E PubMedGoogle Scholar
  59. 59.
    Kanagala R et al (2003) Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 107(20):2589–2594PubMedGoogle Scholar
  60. 60.
    Peker Y, Carlson J, Hedner J (2006) Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 28(3):596–602. doi: 10.1183/09031936.06.00107805 PubMedGoogle Scholar
  61. 61.
    Yumino D et al (2007) Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol 99(1):26–30. doi: 10.1016/j.amjcard.2006.07.055 PubMedGoogle Scholar
  62. 62.
    Peker Y et al (2000) Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 162(1):81–86PubMedGoogle Scholar
  63. 63.
    Gottdiener JS et al (2000) Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 35(6):1628–1637. doi: 10.1016/S0735-1097(00)00582-9 PubMedGoogle Scholar
  64. 64.
    Grebe M et al (2006) Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 173(8):897–901. doi: 10.1164/rccm.200508-1223OC PubMedGoogle Scholar
  65. 65.
    El Solh AA et al (2007) Endothelial cell apoptosis in obstructive sleep apnea: A link to endothelial dysfunction. Am J Respir Crit Care MedGoogle Scholar
  66. 66.
    Ip MS et al (2004) Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 169(3):348–353. doi: 10.1164/rccm.200306-767OC PubMedGoogle Scholar
  67. 67.
    Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115(10):1285–1295PubMedGoogle Scholar
  68. 68.
    Prior JO et al (2005) Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation 111(18):2291–2298. doi: 10.1161/01.CIR.0000164232.62768.51 PubMedGoogle Scholar
  69. 69.
    Bugiardini R et al (2004) Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 109(21):2518–2523. doi: 10.1161/01.CIR.0000128208.22378.E3 PubMedGoogle Scholar
  70. 70.
    De Vriese AS et al (2004) Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia. Circulation 109(19):2331–2336. doi: 10.1161/01.CIR.0000129138.08493.4D PubMedGoogle Scholar
  71. 71.
    MacCarthy PA, Shah AM (2000) Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy. Circulation 101(15):1854–1860PubMedGoogle Scholar
  72. 72.
    Chen L et al (2005) Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. Am J Respir Crit Care Med 172(7):915–920. doi: 10.1164/rccm.200504-560OC PubMedGoogle Scholar
  73. 73.
    Amin RS et al (2002) Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med 165(10):1395–1399. doi: 10.1164/rccm.2105118 PubMedGoogle Scholar
  74. 74.
    Otto ME et al (2007) Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol 99(9):1298–1302. doi: 10.1016/j.amjcard.2006.12.052 PubMedGoogle Scholar
  75. 75.
    Shivalkar B et al (2006) Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol 47(7):1433–1439. doi: 10.1016/j.jacc.2005.11.054 PubMedGoogle Scholar
  76. 76.
    Dursunoglu N et al (2007) Effects of CPAP on left ventricular structure and myocardial performance index in male patients with obstructive sleep apnoea. Sleep Med 8(1):51–59. doi: 10.1016/j.sleep.2006.04.007 PubMedGoogle Scholar
  77. 77.
    Alchanatis M et al (2002) Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J 20(5):1239–1245. doi: 10.1183/09031936.02.00278002 PubMedGoogle Scholar
  78. 78.
    Gami AS et al (2007) Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 49(5):565–571. doi: 10.1016/j.jacc.2006.08.060 PubMedGoogle Scholar
  79. 79.
    Tremel F et al (1999) High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J 20(16):1201–1209. doi: 10.1053/euhj.1999.1546 PubMedGoogle Scholar
  80. 80.
    Trupp RJ et al (2004) Prevalence of sleep disordered breathing in a heart failure program. Congest Heart Fail (Greenwich, Conn) 10(5):217–220. doi: 10.1111/j.1527-5299.2004.03557.x
  81. 81.
    Tamura A et al (2007) Relationship between beta-blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest 131(1):130–135. doi: 10.1378/chest.06-0919 PubMedGoogle Scholar
  82. 82.
    Eikermann M et al (2007) The influence of aging on pharyngeal collapsibility during sleep. Chest 131(6):1702–1709. doi: 10.1378/chest.06-2653 PubMedGoogle Scholar
  83. 83.
    Abraham WT et al (2006) Validation and clinical utility of a simple in-home testing tool for sleep-disordered breathing and arrhythmias in heart failure: results of the Sleep Events, Arrhythmias, and Respiratory Analysis in Congestive Heart Failure (SEARCH) study. Congest Heart Fail (Greenwich, Conn) 12(5):241–247, quiz 248-9. doi: 10.1111/j.1527-5299.2006.05693.x Google Scholar
  84. 84.
    Young T, Skatrud J, Peppard PE (2004) Risk factors for obstructive sleep apnea in adults. J Am Med Assoc 291(16):2013–2016. doi: 10.1001/jama.291.16.2013 PubMedGoogle Scholar
  85. 85.
    Arzt M et al (2006) Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med 166(16):1716–1722. doi: 10.1001/archinte.166.16.1716 PubMedGoogle Scholar
  86. 86.
    Engleman HM et al (1994) Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 343(8897):572–575. doi: 10.1016/S0140-6736(94)91522-9 PubMedGoogle Scholar
  87. 87.
    Yoshinaga K et al (2007) The effects of continuous positive airway pressure on myocardial energetics in patients with heart failure and obstructive sleep apnea. J Am Coll Cardiol 49(4):450–458. doi: 10.1016/j.jacc.2006.08.059 PubMedGoogle Scholar
  88. 88.
    Tkacova R et al (1998) Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 98(21):2269–2275PubMedGoogle Scholar
  89. 89.
    Tkacova R et al (1997) Effect of continuous positive airway pressure on mitral regurgitant fraction and atrial natriuretic peptide in patients with heart failure. J Am Coll Cardiol 30(3):739–745. doi: 10.1016/S0735-1097(97)00199-X PubMedGoogle Scholar
  90. 90.
    Maser RE et al (2008) Continuous positive airway pressure therapy improves cardiovascular autonomic function for persons with sleep-disordered breathing. Chest 133(1):86–91. doi: 10.1378/chest.07-1580 PubMedGoogle Scholar
  91. 91.
    Johnson KG, Johnson DC (2005) Bilevel positive airway pressure worsens central apneas during sleep. Chest 128(4):2141–2150. doi: 10.1378/chest.128.4.2141 PubMedGoogle Scholar
  92. 92.
    Parthasarathy S, Tobin MJ (2004) Sleep in the intensive care unit. Intensive Care Med 30(2):197–206. doi: 10.1007/s00134-003-2030-6 PubMedGoogle Scholar
  93. 93.
    Gay PC, Herold DL, Olson EJ (2003) A randomized, double-blind clinical trial comparing continuous positive airway pressure with a novel bilevel pressure system for treatment of obstructive sleep apnea syndrome. Sleep 26(7):864–869PubMedGoogle Scholar
  94. 94.
    Kaneko Y et al (2003) Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348(13):1233–1241PubMedGoogle Scholar
  95. 95.
    Mansfield DR et al (2004) Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 169(3):361–366. doi: 10.1164/rccm.200306-752OC PubMedGoogle Scholar
  96. 96.
    Bendjelid K et al (2005) Does continuous positive airway pressure by face mask improve patients with acute cardiogenic pulmonary edema due to left ventricular diastolic dysfunction? Chest 127(3):1053–1058. doi: 10.1378/chest.127.3.1053 PubMedGoogle Scholar
  97. 97.
    Chadda K et al (2002) Cardiac and respiratory effects of continuous positive airway pressure and noninvasive ventilation in acute cardiac pulmonary edema. Crit Care Med 30(11):2457–2461. doi: 10.1097/00003246-200211000-00009 PubMedGoogle Scholar
  98. 98.
    Bellone A et al (2002) Acute effects of non-invasive ventilatory support on functional mitral regurgitation in patients with exacerbation of congestive heart failure. Intensive Care Med 28(9):1348–1350. doi: 10.1007/s00134-002-1424-1 PubMedGoogle Scholar
  99. 99.
    Nadar S et al (2005) Positive pressure ventilation in the management of acute and chronic cardiac failure: a systematic review and meta-analysis. Int J Cardiol 99(2):171–185. doi: 10.1016/j.ijcard.2004.03.047 PubMedGoogle Scholar
  100. 100.
    Lin M et al (1995) Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Short-term results and long-term follow-up. Chest 107(5):1379–1386. doi: 10.1378/chest.107.5.1379 Google Scholar
  101. 101.
    Baratz DM et al (1992) Effect of nasal continuous positive airway pressure on cardiac output and oxygen delivery in patients with congestive heart failure. Chest 102(5):1397–1401. doi: 10.1378/chest.102.5.1397 PubMedGoogle Scholar
  102. 102.
    Spaak J et al (2005) Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea. Hypertension 46(6):1327–1332. doi: 10.1161/01.HYP.0000193497.45200.66 PubMedGoogle Scholar
  103. 103.
    Usui K et al (2005) Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 45(12):2008–2011. doi: 10.1016/j.jacc.2004.12.080 PubMedGoogle Scholar
  104. 104.
    Kaye DM et al (2001) Acute effects of continuous positive airway pressure on cardiac sympathetic tone in congestive heart failure. Circulation 103(19):2336–2338PubMedGoogle Scholar
  105. 105.
    Khoo MC et al (2001) Cardiac autonomic control in obstructive sleep apnea: effects of long-term CPAP therapy. Am J Respir Crit Care Med 164(5):807–812PubMedGoogle Scholar
  106. 106.
    Fonarow GC et al (2005) Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. J Am Med Assoc 293(5):572–580. doi: 10.1001/jama.293.5.572 PubMedGoogle Scholar
  107. 107.
    Krumholz HM et al (1997) Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 157(1):99–104. doi: 10.1001/archinte.157.1.99 PubMedGoogle Scholar
  108. 108.
    Moritz F et al (2007) Continuous positive airway pressure versus bilevel noninvasive ventilation in acute cardiogenic pulmonary edema: a randomized multicenter trial. Ann Emerg Med 50(6):666–675, 675 e1Google Scholar
  109. 109.
    Park M et al (2004) Randomized, prospective trial of oxygen, continuous positive airway pressure, and bilevel positive airway pressure by face mask in acute cardiogenic pulmonary edema. Crit Care Med 32(12):2407–2415. doi: 10.1097/01.CCM.0000147770.20400.10 PubMedGoogle Scholar
  110. 110.
    Acosta B et al (2000) Hemodynamic effects of noninvasive bilevel positive airway pressure on patients with chronic congestive heart failure with systolic dysfunction. Chest 118(4):1004–1009. doi: 10.1378/chest.118.4.1004 PubMedGoogle Scholar
  111. 111.
    Mehta S et al (1997) Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema. Crit Care Med 25(4):620–628. doi: 10.1097/00003246-199704000-00011 PubMedGoogle Scholar
  112. 112.
    Solin P et al (1999) Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 99(12):1574–1579PubMedGoogle Scholar
  113. 113.
    Roebuck T et al (2004) Increased long-term mortality in heart failure due to sleep apnoea is not yet proven. Eur Respir J 23(5):735–740. doi: 10.1183/09031936.04.00060404 PubMedGoogle Scholar
  114. 114.
    Naughton MT (2000) Is Cheyne–Stokes respiration detrimental in patients with heart failure? Sleep and Breathing 4(3):127–128. doi: 10.1055/s-2000-11563 PubMedGoogle Scholar
  115. 115.
    Philippe C et al (2005) Compliance with and efficacy of adaptive servo-ventilation (ASV) versus continuous positive airway pressure (CPAP) in the treatment of Cheyne–Stokes respiration in heart failure over a six month periodGoogle Scholar
  116. 116.
    Seino Y et al (2007) Clinical efficacy and cost-benefit analysis of nocturnal home oxygen therapy in patients with central sleep apnea caused by chronic heart failure. Circulation J 71(11):1738–1743. doi: 10.1253/circj.71.1738 PubMedGoogle Scholar
  117. 117.
    Shigemitsu M et al (2007) Nocturnal oxygen therapy prevents progress of congestive heart failure with central sleep apnea. Int J Cardiol 115(3):354–360. doi: 10.1016/j.ijcard.2006.03.018 PubMedGoogle Scholar
  118. 118.
    Sakakibara M et al (2005) Effectiveness of short-term treatment with nocturnal oxygen therapy for central sleep apnea in patients with congestive heart failure. J Cardiol 46(2):53–61PubMedGoogle Scholar
  119. 119.
    Franklin KA et al (1997) Reversal of central sleep apnea with oxygen. Chest 111(1):163–169. doi: 10.1378/chest.111.1.163 PubMedGoogle Scholar
  120. 120.
    Khayat RN et al (2003) Cardiorespiratory effects of added dead space in patients with heart failure and central sleep apnea. Chest 123(5):1551–1560. doi: 10.1378/chest.123.5.1551 PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Martin A. Valdivia-Arenas
    • 1
  • Michael Powers
    • 2
  • Rami N. Khayat
    • 3
  1. 1.Blanchard Valley Health SystemFindlayUSA
  2. 2.OSU Sleep Heart ProgramThe Ohio State UniversityColumbusUSA
  3. 3.Pulmonary, Allergy, Critical Care and Sleep MedicineThe Ohio State UniversityColumbusUSA

Personalised recommendations